April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Protective Role of ICOS/B7RP-1 Pathway in Acceptance of Corneal Allografts
Author Affiliations & Notes
  • J. Hori
    Ophthalmology, Nippon Medical School, Bunkyo-Ku, Japan
  • H. Taniguchi
    Ophthalmology, Nippon Medical School, Bunkyo-Ku, Japan
  • M. Wang
    Ophthalmology, Nippon Medical School, Bunkyo-Ku, Japan
  • H. Akiba
    Immunology, Juntendo University School of Medicine, Bunkyo-Ku, Japan
  • H. Yagita
    Immunology, Juntendo University School of Medicine, Bunkyo-Ku, Japan
  • Footnotes
    Commercial Relationships  J. Hori, None; H. Taniguchi, None; M. Wang, None; H. Akiba, None; H. Yagita, None.
  • Footnotes
    Support  Grants-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3035. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Hori, H. Taniguchi, M. Wang, H. Akiba, H. Yagita; Protective Role of ICOS/B7RP-1 Pathway in Acceptance of Corneal Allografts. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3035.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The inducible costimulatory molecule (ICOS) is a member of the CD28/CTLA-4 family. Interaction between ICOS and its ligand, B7 related protein (B7RP)-1, has been reported to promote T cell responses. It has also been indicated that ICOS has an impact on differentiation and functions of various T regulatory cells, such as naturally occurring T regulatory cells, Tr1, and CD8+ T regulatory cells. The purpose of the present study is to investigate the role of ICOS/B7RP-1 pathway in immune responses after corneal allo-transplantation.

Methods: : Normal corneas of C57BL/6 were transplanted orthotopically into normal eyes of BALB/c mice. Recipients were administrated intraperitoneally with 0.25 mg of anti-B7RP-1 monoclonal antibody (mAb) or isotype control rat IgG three times a week for 3 weeks after grafting. Graft survival and corneal neovascurlarization were evaluated. Acquisition of donor-specific delayed type hypersensitivity in the recipients was assessed. C57BL/6 cornea was also transplanted in the eyes of BALB/c mice depleted CD25+CD4+ T regulatory cells by the previous administration of a high dose of anti-CD25 mAb. ICOS expression in the cervical lymph nodes in the allograft-bearing recipients was assessed by flowcytometry.

Results: : Allograft survival in the recipients treated with anti-B7RP-1 mAb was significantly shorter than that in the control recipients. Donor-specific delayed hypersensitivity was induced in the recipients with ICOS/B7RP-1 blockade. Neovascularization into the corneal allografts in the recipients treated with anti-B7RP-1 mAb was significantly more sever than that in the control recipients. In the cervical lymph nodes of the CD25+CD4+Treg-depleted recipients bearing corneal allografts, the proportion of ICOS+CD8+T cells increased.

Conclusions: : ICOS/B7RP-1 pathway plays a protective role in acceptance of corneal allografts. ICOS/B7RP-1 signaling may be mutually influenced by T regulatory cells in immune responses after corneal allo-transplantation.

Keywords: immune tolerance/privilege • immunomodulation/immunoregulation • transplantation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×